News

Two patents for Nencki Institute: new peptides for glioma therapy

03.06.2026

We are pleased to announce that patent protection has been granted for two groups of innovative peptides developed at the Nencki Institute for the treatment of malignant brain tumors. Gliomas are among the most common and most difficult-to-treat cancers of the central nervous system in adults, and patient prognosis remains extremely poor (90% of patients do not survive more than 3 years after diagnosis). Both inventions are the result of many years of research conducted by the team of ...

2nd Symposium of the Dioscuri Centre for Metabolic Diseases

03.06.2026

On 27 May, the Nencki Institute of Experimental Biology, Polish Academy of Sciences, hosted the 2nd Symposium of the Dioscuri Centre for Metabolic Diseases. The event focused on fundamental ...

Inauguration of the Translational Research Center at the Nencki Institute (in Polish)

27.05.2026

Profesor Agnieszka Dobrzyń, Dyrektor Instytutu ma zaszczyt zaprosić na uroczystą inaugurację Centrum Badań Translacyjnych Instytutu Nenckiego, która odbędzie się w dniu 17 czerwca 2026 r. o godz ...

Patents for inventions related to epilepsy prediction developed in collaboration with Nencki Institute

22.05.2026

We are pleased to announce that two inventions entitled “Panel of predictive markers, method for predicting the occurrence of drug-resistant epilepsy in girls aged up to 24 months with tuberous ...

Nobel Laureate visits the Nencki Institute

12.05.2026

On May 6, 2026, the Nencki Institute had the honor of hosting Professor Stefan Hell - a German physicist, recipient of the 2014 Nobel Prize in Chemistry, and pioneer of super-resolution ...